Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Acquisition
Pfizer to Acquire FoldRx Pharmaceuticals
September 01, 2010
Lead product candidate tafamidis meglumine in EU Registration
Meda acquires Alaven, a US specialty pharma company
August 30, 2010
Strengthens position in the strategic US market
Fresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro
August 26, 2010
Fresenius expands its activities in the homecare market in Europe and Asia-Pacific
BioMarin Acquires ZyStor Therapeutics, Inc.
August 17, 2010
ZyStor's lead product candidate is ZC-701
Medtronic Signs Agreement to Acquire Osteotech
August 17, 2010
Acquisition Will Expand Product Offering, Pipeline and New Markets for Biologics Business
Cypress Bioscience Responds to Unsolicited, Non-Binding Proposal and Recent Letter From Ramius LLC
August 06, 2010
Proposal thoroughly review by Board of Directors and financial and legal advisors
Victory Pharma Completes Acquisition of Assets of MiddleBrook Pharmaceuticals
August 03, 2010
Company Expands Product Portfolio, Adds Drug Delivery Technology
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
July 30, 2010
Former Idun Management team to expand efforts in liver disease and oncology
Lilly Announces Completion of Alnara Acquisition
July 20, 2010
Lilly makes upfront payment of $180 million
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
July 15, 2010
HealthTronics becomes a wholly-owned subsidiary of Endo Pharmaceuticals
Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics Inc.
July 13, 2010
Diagnostic technologies will strengthen and complement Radient's core business
Lilly to Acquire Alnara Pharmaceuticals
July 02, 2010
Alnara's Pancreatic Enzyme Replacement Therapy, Liprotamase, Currently Under FDA Review
Astellas Announces Successful Completion of Tender Offer for Shares of OSI
June 08, 2010
Subsequent Offer Period Has Expired; Merger to be Completed Shortly
Grifols to Acquire Talecris Biotherapeutics
June 07, 2010
Acquisition to create a world leading provider of life-saving plasma protein therapies
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd.
June 01, 2010
Acquisition strengthens pulmonary focus
Bard Announces Agreement to Acquire SenoRx, Inc.
May 05, 2010
SenoRx to be Acquired for approximately $200 million
Medtronic Signs Agreement to Acquire ATS Medical
April 29, 2010
Acquisition Will Expand Access to Innovative Treatment Options for Structural Heart Disease
Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender Offer
April 19, 2010
Javelin's post-operative pain drug would strengthen acute-care offering
VaxGen to Acquire diaDexus in a Stock-for-Stock Merger
April 14, 2010
diaDexus will use cash to fund continued adoption of the PLAC(R) Test
PerkinElmer Enters Into Agreement to Acquire Signature Genomic Laboratories, LLC
April 14, 2010
Acquisition brings new diagnostic services to global leader in pre-natal and newborn health screening
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
April 09, 2010
Acquisition Diversifies Global Pharmaceutical Business
Fate Therapeutics Expands Stem Cell Modulator Pipeline with Acquisition of Verio Therapeutics
April 08, 2010
Fate Therapeutics forms a Canadian subsidiary
Cephalon Completes Acquisition of Ception Therapeutics
April 05, 2010
Acquisition Adds Biologics Asset for Advancement to Phase Three Development
Abbott Completes Acquisition of STARLIMS Technologies
March 22, 2010
Abbott pays $123 million for STARLIMS Technologies Ltd
Astellas Responds to OSI Pharmaceuticals' Rejection
March 15, 2010
Astellas' All-Cash Offer Provides Immediate, Full Value to OSI Stockholders
OSI Pharmaceuticals' Board of Directors Unanimously Rejects Astellas' Unsolicited Tender Offer
March 15, 2010
Board Concludes Offer Does Not Fully Reflect OSI's Fundamental, Intrinsic Value
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
March 09, 2010
Abbott will acquire Facet for $27 per share in cash
Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash
March 02, 2010
Astellas Files Lawsuit Against OSI
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
March 01, 2010
Astellas to build a world-class oncology platform
Cephalon Exercises its Option to Acquire Ception Therapeutics
February 23, 2010
Ception Delivers Positive Results from a Phase II Study of CINQUIL in Adult Eosinophilic Asthma
Latest News
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Most Popular
Most Emailed
Most Recent
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Novartis receives FDA approval of Tekamlo
Meda acquires Alaven, a US specialty pharma company
XenoPort Announces Changes to Executive Team
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Pfizer to Acquire FoldRx Pharmaceuticals
Medicis Announces Approval of Additional Strengths of Solodyn(R)
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Meda acquires Alaven, a US specialty pharma company
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Biodel Announces Name Change for Lead Product Candidate
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Medicis Announces Approval of Additional Strengths of Solodyn(R)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Diagnostic
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Regulatory Approval
Research & Development